Flavonoids, vascular function and cardiovascular protection

Current Pharmaceutical Design

Volumn 15, Issue 10, 2009, Pages 1072-1084

  Grassi, Davide ^a   Desideri, Giovambattista ^a   Croce, Giuseppe ^a   Tiberti, Sergio ^a   Aggio, Annalisa ^a   Ferri, Claudio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Blood pressure; Cardiovascular disease; Chocolate; Cocoa; Endothelial function; Flavanols; Flavonoids; Tea

Indexed keywords

ANTIOXIDANT; FLAVANOL DERIVATIVE; FLAVONOID; PLACEBO; POLYPHENOL DERIVATIVE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BEVERAGE; BIOAVAILABILITY; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIETARY INTAKE; DISEASE MODEL; EPIDEMIOLOGICAL DATA; FRUIT; HEART INFARCTION; HEART PROTECTION; HUMAN; INTESTINE ABSORPTION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STROKE; TEA; VEGETABLE;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; BLOOD PRESSURE; BLOOD VESSELS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FLAVONOIDS; FOOD ANALYSIS; HUMANS;

EID: 65649100099     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209787846982     Document Type: Review

References (123)

1. Geleijnse JM, Hollman PCh. Flavonoids and cardiovascular health: which compounds, what mechanisms? Am J Clin Nutr 2008; 88(1): 12-3.
2. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr 2005; 81(1 Suppl): 215S-217S.
3. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79(5): 727-47.
4. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007; 137(3 Suppl 1): 718S-737S.
5. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, et al. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 2004; 134(3): 613-7.
6. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996; 14; 275(6): 447-51.
7. Mennen LI, Sapinho D, de Bree A, Arnault N, Bertrais S, Galan P, et al. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr 2004; 134(4): 923-6.
8. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342(8878): 1007-11.
9. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995; 155(4): 381-6.
10. Scalbert A, Manach C, Morand C, Remesy C, Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45(4): 287-306.
11. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 2008; 138(9): 1671-6.
12. Ferri C, Grassi G. Mediterranean diet, cocoa and cardiovascular disease: a sweeter life, a longer life, or both? J Hypertens 2003; 21(12): 2231-4.
13. Ferri C, Grassi D, Grassi G. Cocoa beans, endothelial function and aging: an unexpected friendship? J Hypertens 2006; 24 (8): 1471-4.
14. Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005; 81(3): 611-4.
15. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005; 46(2): 398-405.
16. Stocker R, O'Halloran RA. Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall. Am J Clin Nutr 2004; 79: 123-130.
17. Auger C, Gerain P, Laurent-Bichon F, Portet K, Bornet A, Caporiccio B, et al. Phenolics from commercialized grape extracts prevent early atherosclerotic lesions in hamsters by mechanisms other than antioxidant effect. J Agric Food Chem 2004; 52: 5297-5302.
18. Manach C, Williamson G, Morand C, Scalbert A, Re'me'sey C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81(1 Suppl): 230S-42S.
19. Williamson G, Barron D, Shimoi K, Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 2005; 39: 457-69.
20. Silberberg M, Morand C, Manach C, Scalbert A, Remesy C. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci 2005; 77(25): 3156-67.
21. Csonka A. Hungary makes slow progress in health-system reform Private funds, which could rescue Hungary's ailing health-care system, have been slow to materialise. Lancet 2004; 363(9425): 1957-60.
22. Rusznyak I, Szent-Györgyi A. Vitamin P: flavanols as vitamins. Nature 1936; 138: 27.
23. Croft KD. The chemistry and biological effects of flavonoids and phenolic acids. Ann N Y Acad Sci 1998; 854: 435-42.
24. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000; 63(7): 1035-42.
25. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993; 300(2): 535-43.
26. Lampe JW. Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr 1999; 70(3 Suppl): 475S-490S.
27. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004; 36(7): 838-49.
28. Schewe T, Steffen Y, Sies H. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 2008; 476(2): 102-6.
29. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 2006; 54(1): 229-34.
30. Ferri C, Croce G, Cofini V, De Berardinis G, Grassi D, Casale R, et al. C-reactive protein. Interaction with the vascular endothelium and possible role in human atherosclerosis. Curr Pharm Des 2007; 13(16): 1631-45.
31. Harrison DG. Endothelial function and oxidant stress. Clin Cardiol 1997; 20(11 Suppl 2): II-11-7
32. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44(3): 248-52.
33. Desideri G, Ferri C. Endothelial activation. Sliding door to atherosclerosis. Curr Pharm Des 2005; 11(17): 2163-75.
34. Huk I, Brovkovych V, Nanobash Vili J, Weigel G, Neumayer C, Partyka L, et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg 1998; 85(8): 1080-5.
35. Choi JS, Chung HY, Kang SS, Jung MJ, Kim JW, No JK, et al. The structure-activity relationship of flavonoids as scavengers of peroxynitrite. Phytother Res 2002; 16(3): 232-5.
36. van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 1995; 214(3): 755-9.
37. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74(4): 418-25.
38. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
39. Buijsse B, Feskens EJ, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 2006; 166(4): 411-7.
40. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81(1 Suppl): 317S-325S.
41. Lee IM, Paffenbarger RS Jr. Life is sweet: candy consumption and longevity. BMJ 1998; 317(7174): 1683-4.
42. Bayard V, Chamorro F, Motta J, Hollenberg NK. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in panama. Int J Med Sci 2007; 4(1): 53-8.
43. Hollenberg NK, Martinez G, McCullough M, Meinking T, Passan D, Preston M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 1997; 29(1 Pt 2): 171-6.
44. Chevaux KA, Jackson L, Villar ME, Mundi JA, Commisso JF, Adamson GE. Proximate mineral and procyanidin content of certain foods and beverages consumed by the Kuna Amerinds of Panama. J Food Comp Analysis 2001; 14: 553-563
45. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85(3): 895-909.
46. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002; 75(5): 880-6.
47. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation 2002; 105(21): 2476-81.
48. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 1999; 149: 162-7.
49. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000; 13(1-4): 49-54.
50. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006; 296(10): 1255-65.
51. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997; 65(5): 1489-94.
52. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 1999; 53(8): 481-7.
53. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? a meta-analysis. Am J Epidemiol 2001; 154: 495-503.
54. Vane JR, Anggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
55. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Working group on endothelin and endothelial factors of the european society of hypertension. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European Society of Hypertension. J Hypertens 2005; 23(1): 7-17.
56. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Working group on endothelins and endothelial factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European Society of Hypertension. J Hypertens 2005; 23(2): 233-46.
57. Grassi D, Aggio A, Onori L, Croce G, Tiberti S, Ferri C, et al. Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr 2008; 138(8): 1554S-1560S.
58. Boulanger G, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590.
59. Kourembanas S, Mcquillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors on growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993; 92: 99-104.
60. Luscher TF, Yang Z, von Segesser L, Stulz P, Boulanger C, Siebemann R, et al. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990; 66: 1088-1094.
61. Lerman A, Sandok EK, Hildebrand FL Jr, Burnett JC Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 1992; 85: 1894-1898.
62. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
63. Halcox JP, Nour KR, Zalos G, Quyyumi AA. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ETA receptor blockade. Circ Res 2001; 89: 969-976.
64. Kinlay S, Behrendt D, Wainstein M, Beltrame J, Fang JC, Creager MA, et al. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation 2001; 104: 1114-1118.
65. Ferri C, Bellini C, Desideri G, Mazzocchi C, De Siati L, Santucci A. Elevated plasma and urinary endothelin-I levels in human salt-sensitive hypertension. Clin Sci (Lond) 1997; 93(1): 35-41.
66. Bagg W, Ferri C, Desideri G, Gamble G, Ockelford P, Braatvedt GD. The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes. J Clin Endocrinol Metab 2001; 86(11): 5491-7.
67. Schmitt M, Avolio A, Qasem A, McEniery C, Butlin M, Wilkinson I, et al. Basal NO locally modulates human iliac artery function in vivo. Hypertension 2005; 46: 227-231.
68. Dobrin PB, Rovick AA. Influence of vascular smooth muscle on contractile mechanisms and elasticity of arteries. Am J Physiol 1969; 217: 1644-1651.
69. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105: 213-217.
70. McEniery CM, Qasem A, Schmitt M, Avolio A, Cockcroft JR, Wilkinson IB. Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 2003; 42: 1975-1981.
71. Joannides R, Richard V, Haefeli WE, Benoist A, Linder L, Lusher TF, et al. Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension 1997; 30: 1465-1470.
72. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of arterial hypertension of the european society of hypertension; European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-87.
73. Zieman S, Melenovsky V, Kass D. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943.
74. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993; 265(2 Pt 2): H774-8.
75. Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 1995; 26(1): 90-5.
76. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 2000; 130(8S Suppl): 2105S-8S.
77. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 2004; 13; 279(7): 6190-5.
78. Benito S, Lopez D, Saiz MP, Buxaderas S, Sanchez J, Puig-Parellada, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 2002; 135(4): 910-6.
79. Leikert JF, Räthel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002; 106(13): 1614-7.
80. Wallerath T, Poleo D, Li H, Förstermann U. Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 2003; 41(3): 471-8.
81. Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, Keaney JF, Jr. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 2004; 279: 46637-43.
82. Jochmann N, Lorenz M, Krosigk A, Martus P, Böhm V, Baumann G, et al. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 2008; 99(4): 863-8.
83. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006; 24; 103(4): 1024-9.
84. Heiss C, Kleinbongard P, Dejam A, Perre S, Schroeter H, Sies H, et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 2005; 46(7): 1276-83.
85. Fisher ND, Hollenberg NK. Aging and vascular responses to flavanol-rich cocoa. J Hypertens 2006; 24(8): 1575-80.
86. Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 2003; 21: 2281-2286.
87. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 2004; 23(3): 197-204.
88. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008; 88(1): 38-50.
89. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA 2003; 290: 1030-1031.
90. Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 2008; 51(22): 2141-9.
91. Faridi Z, Njike VY, Dutta S, Ali A, Katz DL. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 2008; 88(1): 58-63.
92. Flammer AJ, Hermann F, Sudano I, Spieker L, Hermann M, Cooper KA, et al. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 2007; 116(21): 2376-82.
93. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 2008; 88(4): 1018-25.
94. Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 2007; 26: 95-102.
95. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001; 104: 151-6.
96. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ. Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 2002; 102: 195-201.
97. Ardalan MR, Tarzamni MK, Shoja MM, Tubbs RS, Rahimi-Ardabili B, Ghabili K, et al. Black tea improves endothelial function in renal transplant recipients. Transplant Proc 2007; 9: 1139-42.
98. Hodgson JM, Burke V, Puddey IB. Acute effects of tea on fasting and postprandial vascular function and blood pressure in humans. J Hypertens 2005; 23: 47-54.
99. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 2007; 298(1): 49-60.
100. Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 2007; 167(7): 626-34.
101. Taubert D, Berkels R, Roesen R, Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 2003; 290: 1029-1030.
102. Fraga CG, Actis-Goretta L, Ottaviani JI, Carrasquedo F, Lotito SB, Lazarus S, et al. Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin Dev Immunol 2005; 12: 11-17.
103. McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr 2002; 21(1): 1-13.
104. Hodgson JM, Devine A, Puddey IB, Chan SY, Beilin LJ, Prince RL. Tea intake is inversely related to blood pressure in older women. J Nutr 2003; 133(9): 2883-6.
105. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med 2004; 164(14): 1534-40.
106. Keli S, Hertog M, Feskens E, Kromhout D. Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen Study. Arch Intern Med 1996; 156: 637-42.
107. Stensvold I, Tverdal A, Solvoll K, Foss OP. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 1992; 21: 546-53.
108. Persson IA, Josefsson M, Persson K, Andersson RG. Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 2006; 58: 1139-44.
109. Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008; 28(3): s11-6.
110. Pignatelli P, Di Santo S, Buchetti B, Sanguigni V, Brunelli A, Violi F. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. FASEB J 2006; 20: 1082-1089.
111. Rein D, Paglieroni TG, Wun T, Pearson DA, Schmitz HH, Gosselin R, et al. Cocoa inhibits platelet activation and function. Am J Clin Nutr 2000; 72(1): 30-5.
112. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000; 130(1): 53-6.
113. Pearson DA, Paglieroni TG, Rein D, Wun T, Schramm DD, Wang JF, et al. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res 2002; 106(4-5): 191-7.
114. Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, et al. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr.2003; 77(6): 1466-73.
115. Kelly FD, Sinclair AJ, Mann NJ, Turner AH, Abedin L, Li D. A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. Eur J Clin Nutr 2001; 55(2): 88-96.
116. Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SA, et al. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 2001; 73(1): 36-40.
117. Son DJ, Cho MR, Jin YR, Kim SY, Park YH, Lee SH, et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 25-31.
118. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr 2001; 55: 881-886.
119. Wolfram R, Oguogho A, Efthimiou Y, Budinsky A, Sinzinger H. Effect of black tea on (iso-) prostaglandins and platelet aggregation in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 529-533.
120. Duffy SJ, Vita JA, Holbrook M, Swerdloff PL, Keaney JF Jr. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 1084-1089.
121. Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens 2008; 26(4): 685-90.
122. Strbian D, Durukan A, Tatlisumak T. Rodent models of hemorrhagic stroke. Curr Pharm Des 2008; 14(4): 352-8.
123. Virdis A, Ghiadoni L, Versari D, Giannarelli C, Salvetti A, Taddei S. Endothelial function assessment in complicated hypertension. Curr Pharm Des 2008; 14(18): 1761-70.